{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:59Z","timestamp":1786113059672,"version":"build-2736575974"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Dyslipidemia is prevalent among Nigerians with diabetes mellitus (DM), but its treatment has not been well-studied. The objective of this study was to determine the prevalence, treatment rates and control of dyslipidemia among DM patients in northern Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter, cross-sectional study of dyslipidemia in DM patients, and noted cardiovascular disease (CVD) risk factors, lipid-lowering treatments, body mass index, blood pressure, HbA1c, lipid profile, glomerular filtration rate and proteinuria. Outcome measures were the rate and treatment of dyslipidemia and attainment of low density lipoprotein cholesterol target for primary prevention of CVD. Binomial logistic regression was used to analyze associations between participant characteristics and dyslipidemia. Hosmer-Lemeshow goodness-of-fit test was used to evaluate the model fit. Statistical analysis was performed with the SPSS version 25 program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study enrolled 403 participants (58.8% females), of whom 59.6% had dyslipidemia. Besides DM and dyslipidemia, other risk factors for CVD were hypertension (56.8%), obesity (52.6%), chronic kidney disease (36.5%), atrial fibrillation (7.9%), heart failure (5.0%), cigarette smoking (4.7%), excess alcohol use (2.0%), and previous CVD (14.4%). Logistic regression analysis showed dyslipidemia was significantly associated with female gender (odds ratio\u2009=\u20091.68,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) and proteinuria (odds ratio\u2009=\u20092.26,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004). Among those with dyslipidemia, 51.3% took lipid-lowering treatments comprising statins (50.8%) and clofibrate (2.9%). None took other lipid-lowering treatments, and only 17.1% attained the target for primary prevention of CVD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Three-fifths of patients had dyslipidemia, but only a sixth attained the treatment target. Treatment for dyslipidemia included statins and fibrates, but not niacin, ezetimibe, bempedoic acid, icosapent ethyl, inclisiran or PCSK9 inhibitors recommended for those who failed intensive statin therapy. There is the need for better access to non-statin treatment and physician adherence to clinical practice guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0346350","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:27:48Z","timestamp":1785950868000},"page":"e0346350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, treatment rates and control of dyslipidemia among diabetes patients in northern Nigeria: A cross-sectional, multicenter study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-325X","authenticated-orcid":true,"given":"Nura Hamidu","family":"Alkali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Enemako","family":"Uloko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-0548","authenticated-orcid":true,"given":"Godwin O.","family":"Osaigbovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamu Girei","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Raji","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ahuoiza","family":"Garba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garba Musa","family":"Fika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar Sahabi","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Arabi","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandi Ghyi","family":"Zira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar Faruk","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuba","family":"Mugana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijuptil","family":"Chiroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Abdullahi","family":"Haladu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumsami","family":"Shadrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman Adamu","family":"Nuhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godiya Ishaya","family":"Dare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"pone.0346350.ref001","author":"World Health Organization"},{"issue":"10397","key":"pone.0346350.ref002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"pone.0346350.ref003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamapediatrics.2023.2029","article-title":"Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019","volume":"177","author":"K Zhang","year":"2023","journal-title":"JAMA Pediatr"},{"key":"pone.0346350.ref004","first-page":"200189","article-title":"Diabetes Mellitus as a risk factor for stroke among Nigerians: A systematic review and meta-analysis","volume":"18","author":"TA Azeez","year":"2023","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"8","key":"pone.0346350.ref005","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/dc12-1513","article-title":"All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database","volume":"36","author":"KS Taylor","year":"2013","journal-title":"Diabetes Care"},{"issue":"7343","key":"pone.0346350.ref006","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/bmj.324.7343.939","article-title":"Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies","volume":"324","author":"JMM Evans","year":"2002","journal-title":"BMJ"},{"issue":"11","key":"pone.0346350.ref007","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/biomedicines9111602","article-title":"Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors","volume":"9","author":"E Hasheminasabgorji","year":"2021","journal-title":"Biomedicines"},{"issue":"7","key":"pone.0346350.ref008","article-title":"Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study","volume":"10","author":"AD Kaze","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"pone.0346350.ref009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-024-02046-8","article-title":"Sexual dysfunction in patients with diabetes: association between remnant cholesterol and erectile dysfunction","volume":"23","author":"K Huang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"pone.0346350.ref010","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2147\/DMSO.S419794","article-title":"The Association Between Lipid Profile and Subfoveal Choroidal Thickness in Chinese Patients with Proliferative Diabetic Retinopathy Secondary to Type 2 Diabetes","volume":"16","author":"C Lei","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"pone.0346350.ref011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jdi.14124","article-title":"Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth","volume":"15","author":"MG Dalfr\u00e0","year":"2024","journal-title":"J Diabetes Investig"},{"key":"pone.0346350.ref012","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","author":"National Institutes of Health","year":"2001"},{"issue":"19","key":"pone.0346350.ref013","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJMe2402653","article-title":"Shooting the Messenger to Treat Hypertriglyceridemia","volume":"390","author":"GF Watts","year":"2024","journal-title":"N Engl J Med"},{"key":"pone.0346350.ref014","doi-asserted-by":"crossref","first-page":"923289","DOI":"10.1155\/2012\/923289","article-title":"Lipoprotein(a): Cellular Effects and Molecular Mechanisms","volume":"2012","author":"K Riches","year":"2012","journal-title":"Cholesterol"},{"issue":"1","key":"pone.0346350.ref015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"pone.0346350.ref016","doi-asserted-by":"crossref","DOI":"10.2337\/db19-619-P","article-title":"619-P: Lipid Profile and Prevalence of Dyslipidemia in Type 1 Diabetes Adults in Spain","volume":"68","author":"MG RODRIGUEZ CARNERO","year":"2019","journal-title":"Diabetes"},{"key":"pone.0346350.ref017","doi-asserted-by":"crossref","first-page":"1002466","DOI":"10.3389\/fpubh.2022.1002466","article-title":"Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors","volume":"10","author":"D Hyassat","year":"2022","journal-title":"Front Public Health"},{"issue":"6","key":"pone.0346350.ref018","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1097\/MS9.0000000000002122","article-title":"Prevalence of dyslipidemia among persons with type 2 diabetes in Africa: a systematic review and meta-analysis","volume":"86","author":"E Ekpor","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"pone.0346350.ref019","first-page":"101","article-title":"Exploring lipid profile abnormalities at first clinical visit in patients with type 2 diabetes mellitus: A regional retrospective cohort study","volume":"7","author":"AO Dada","year":"2024","journal-title":"Asian J Res Reports Endocrinol"},{"issue":"9493","key":"pone.0346350.ref020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"issue":"9753","key":"pone.0346350.ref021","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Collaboration Cholesterol Treatment Trialists\u2019 (CTT)","year":"2010","journal-title":"Lancet"},{"issue":"22","key":"pone.0346350.ref022","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"GG Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0346350.ref023","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"DK Arnett","year":"2019","journal-title":"Circulation"},{"key":"pone.0346350.ref024","author":"NA ElSayed","year":"2023"},{"key":"pone.0346350.ref025","article-title":"International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study","author":"J Brandts","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"pone.0346350.ref026","doi-asserted-by":"crossref","first-page":"1472300","DOI":"10.3389\/fendo.2025.1472300","article-title":"Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting","volume":"16","author":"FA Dhaba","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0346350.ref027","first-page":"123","article-title":"Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria","volume":"34","author":"BO Bello-Ovosi","year":"2019","journal-title":"Pan Afr Med J"},{"issue":"4","key":"pone.0346350.ref028","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/1596-3519.87045","article-title":"Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria","volume":"10","author":"NN Jisieike-Onuigbo","year":"2011","journal-title":"Ann Afr Med"},{"key":"pone.0346350.ref029","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.18203\/2320-6012.ijrms20212501","article-title":"Pattern of serum lipid profile of type 2 diabetes patients in a tertiary hospital in Nigeria","volume":"9","author":"RS Reng","year":"2021","journal-title":"Int J Res Med Sci"},{"issue":"3","key":"pone.0346350.ref030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/1596-3519.188891","article-title":"Prestroke treatment of stroke risk factors: A cross-sectional survey in central Nigeria","volume":"15","author":"NH Alkali","year":"2016","journal-title":"Ann Afr Med"},{"issue":"2","key":"pone.0346350.ref031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/npmj.npmj_54_24","article-title":"Cardiovascular Risk Awareness, Exercise Practices and Metabolic Outcomes among Patients with Diabetes Mellitus in Northern Nigeria: A Cross-sectional, Multicentre Study","volume":"31","author":"NH Alkali","year":"2024","journal-title":"Niger Postgrad Med J"},{"issue":"1","key":"pone.0346350.ref032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12874-022-01694-7","article-title":"Sample size calculation for prevalence studies using Scalex and ScalaR calculators","volume":"22","author":"L Naing","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"15","key":"pone.0346350.ref033","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes","volume":"376","author":"A Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0346350.ref034","unstructured":"National Institutes of Health. Rethinking Drinking: Alcohol and Your Health. NIH Publication No. 21-AA-3770. 2022."},{"key":"pone.0346350.ref035","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III","author":"National Institutes of Health","year":"May, 2001","journal-title":"). NIH Publication"},{"issue":"4","key":"pone.0346350.ref036","doi-asserted-by":"crossref","first-page":"5","DOI":"10.47093\/2218-7332.2020.11.4.5-14","article-title":"Venn diagrams and probability in clinical research","volume":"11","author":"N\u041c Bulanov","year":"2021","journal-title":"jour"},{"issue":"10","key":"pone.0346350.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"JP Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"pone.0346350.ref038","doi-asserted-by":"crossref","first-page":"04353","DOI":"10.7189\/jogh.15.04353","article-title":"Longitudinal insights into comorbidity patterns and burden among middle-aged and older adults with diabetes in China: a nine-year cohort study using CHARLS","volume":"15","author":"H Tang","year":"2025","journal-title":"J Glob Health"},{"issue":"21","key":"pone.0346350.ref039","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in Obesity Among Adults in the United States, 2005 to 2014","volume":"315","author":"KM Flegal","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"pone.0346350.ref040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdi.13697","article-title":"Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort","volume":"13","author":"T Hirano","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"2","key":"pone.0346350.ref041","article-title":"Prevalence and risk factors of chronic kidney disease among Iranian adults with and without diabetes: a cross-sectional study using STEPS 2021 national survey","volume":"16","author":"SM-N Ataei","year":"2026","journal-title":"BMJ Open"},{"key":"pone.0346350.ref042","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"PB Mark","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"pone.0346350.ref043","first-page":"564","article-title":"High burden of chronic kidney disease of unknown cause among patients receiving renal replacement therapy in Northeast Nigeria: A cross-sectional survey of haemodialysis units","volume":"66","author":"BW Goni","year":"2025","journal-title":"Niger Med J"},{"issue":"7","key":"pone.0346350.ref044","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3945\/jn.115.210575","article-title":"Palm Oil Consumption Increases LDL Cholesterol Compared with Vegetable Oils Low in Saturated Fat in a Meta-Analysis of Clinical Trials","volume":"145","author":"Y Sun","year":"2015","journal-title":"J Nutr"},{"issue":"5","key":"pone.0346350.ref045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/nutrit\/nuu060","article-title":"Effect of cheese consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"J de Goede","year":"2015","journal-title":"Nutr Rev"},{"issue":"1","key":"pone.0346350.ref046","doi-asserted-by":"crossref","first-page":"100","DOI":"10.33678\/cor.2022.085","article-title":"Is the Atherogenic Index of Plasma (AIP) a Cardiovascular Disease Marker?","volume":"65","author":"L Askin","year":"2023","journal-title":"Cor Vasa"},{"issue":"1","key":"pone.0346350.ref047","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12944-022-01691-1","article-title":"Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study","volume":"21","author":"J Li","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"1","key":"pone.0346350.ref048","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12944-020-01408-2","article-title":"Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study)","volume":"19","author":"F Bayram","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"1","key":"pone.0346350.ref049","article-title":"Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus","volume":"9","author":"AC Garc\u00eda-Ulloa","year":"2021","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0346350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:27:55Z","timestamp":1785950875000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0346350"}},"subtitle":[],"editor":[{"given":"Gbolahan Deji","family":"Olatunji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0346350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}